BESPARK

What this means for you

Not registered yet, but its 19 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79433020

Mark type

Stylized text

Filed

19 Mar 2025

Goods and services

• Class 005 — Pharmaceuticals: Viral vaccines; vaccines for human use; cells for medical use; antibodies; pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for use in oncology; biological preparations for medical purposes; chemical preparations for medical purposes.
• Class 042 — Scientific and technological services: Scientific laboratory services; analytical laboratory services; technology consultation in the field of artificial intelligence; artificial intelligence consultancy; research in the field of artificial intelligence technology; computer system analysis; design of computer-simulated models; software design for others; biochemistry services; research laboratories; chemistry services; chemical laboratories; engineering services; chemical analysis; conducting technical project studies; electronic data storage; provision of research services; biomedical research services; research relating to biotechnology; pharmaceutical research services; bacteriological research; chemical research; medical and pharmacological research services; research and development of new products for others; research and development services; pharmaceutical research and development; clinical trials; advisory services relating to gene therapy research; research in the field of gene therapy; culturing of cells for scientific research purposes; research and development services relating to vaccines; research and development of vaccines and medicines; medical research; scientific research for medical purposes; medical research in the field of oncology; platform as a service [paas]; software engineering services for data processing programs; technological consultancy services for digital transformation; technological consultancy; technological research; chemical technological research; consultancy services relating to technological research; technical writing; scientific research; scientific research; computer aided scientific research services; scientific research and development; scientific research and analysis; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; biological analysis; biochemical analysis; scientific analysis; consultancy in the field of scientific research; scientific and technological services; testing, authentication and quality control; laboratory analysis in the field of bacteriology; analytical laboratory services; consultancy in the field of industrial research; computer programming services for the analysis of data; computer design and programming services; analysis of product development; quality assurance consultancy; consultancy services relating to quality control; consultancy services relating to quality control; computer aided scientific testing; computer aided testing services; engineering testing; conducting of quality control tests; technical measuring; scientific testing services; scientific testing services; development and test of chemical production methods; development of measuring and testing methods; development of testing methods; design and testing for new product development; analysis and evaluation of product development; laboratory services; product quality control testing; product testing; product quality testing; process monitoring for quality assurance; quality assessment; quality control; inspection of pharmaceuticals; scientific risk assessment; laboratory services relating to the production of monoclonal antibodies; research and development services in the field of antibodies; research and development services in the field of antibody technology; cell culture services for scientific and research purposes, for others.

Owner

• bespark bio GmbH, AT

Prosecution history

• 04 Mar 2026 — ASSIGNED TO EXAMINER
• 12 Feb 2026 — REFUSAL PROCESSED BY IB
• 23 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 23 Jan 2026 — REFUSAL PROCESSED BY MPU
• 20 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 19 Dec 2025 — NON-FINAL ACTION WRITTEN
• 18 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
• 12 Nov 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 11 Nov 2025 — NON-FINAL ACTION WRITTEN
• 23 Sept 2025 — ASSIGNED TO EXAMINER
• 22 Sept 2025 — APPLICATION FILING RECEIPT MAILED
• 22 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 18 Sept 2025 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB